Literature DB >> 22573369

Phenolic compounds isolated from Psoralea corylifolia inhibit IL-6-induced STAT3 activation.

Seung Woong Lee1, Bo Ra Yun, Mi Hwa Kim, Chan Sun Park, Woo Song Lee, Hyun-Mee Oh, Mun-Chual Rho.   

Abstract

Inhibiting interleukin-6 (IL-6) has been postulated as an effective therapy in the pathogenesis of several inflammatory diseases. In this study, seven flavonoids were isolated from the methanol extracts of Psoralea corylifolia by bioactivity-guided fractionation. The structures of bakuchiol (1), bavachinin (2), neobavaisoflavone (3), corylifol A (4), corylin (5), isobavachalcon (6), and bavachin (7) were determined by spectroscopic analysis (1H-, 13C- NMR and MS). We demonstrated that compounds 1-7 showed an inhibitory effect on IL-6-induced STAT3 promoter activity in Hep3B cells with IC50 values of 4.57 ± 0.45, 3.02 ± 0.53, 2.77 ± 0.02, 0.81 ± 0.15, 1.37 ± 0.45, 2.45 ± 0.13, and 4.89 ± 0.05 µΜ, respectively. These compounds also inhibited STAT3 phosphorylation induced by IL-6 in Hep3B cells. Overall, several flavonoids from P. corylifolia might be useful remedies for treating inflammatory diseases by inhibiting IL-6-induced STAT3 activation and phosphorylation. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573369     DOI: 10.1055/s-0031-1298482

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.007


  25 in total

1.  Magnoliae flos Downregulated Lipopolysaccharide-Induced Inflammatory Responses via NF-κB/ERK-JNK MAPK/STAT3 Pathways.

Authors:  Tae-Young Gil; Bo-Ram Jin; Yun-Yeop Cha; Hyo-Jin An
Journal:  Mediators Inflamm       Date:  2022-06-26       Impact factor: 4.529

2.  Molecular Pathway of Psoralidin-Induced Apoptosis in HepG2 Cell Line.

Authors:  Bin Yu; An-Hong Wang; Kun Zhou; Li-Juan Chai; Lu Liu
Journal:  Chin J Integr Med       Date:  2016-03-29       Impact factor: 1.978

3.  Metabolism and disposition of corylifol A from Psoralea corylifolia: metabolite mapping, isozyme contribution, species differences and identification of efflux transporters for corylifol A-O-glucuronide in HeLa1A1 cells.

Authors:  Yang Li; Jinjin Xu; Chunxia Xu; Zifei Qin; Shishi Li; Liufang Hu; Zhihong Yao; Frank J Gonzalez; Xinsheng Yao
Journal:  Xenobiotica       Date:  2020-04-01       Impact factor: 1.908

4.  Metabolic profiling of corylin in vivo and in vitro.

Authors:  Zifei Qin; Shishi Li; Zhihong Yao; Xiaodan Hong; Jinjin Xu; Pei Lin; Guoping Zhao; Frank J Gonzalez; Xinsheng Yao
Journal:  J Pharm Biomed Anal       Date:  2018-03-26       Impact factor: 3.935

5.  Skew-symmetric Random Effect Models with Application to a Preventive Cohort Study: Improving Outcomes in Low Back Pain Patients.

Authors:  Marjan Mansourian; Zahra Mahdiyeh; Jongbae J Park; Shaghayegh Haghjooyejavanmard
Journal:  Int J Prev Med       Date:  2013-03

6.  Characterization of metabolic activity, isozyme contribution and species differences of bavachin, and identification of efflux transporters for bavachin-O-glucuronide in HeLa1A1 cells.

Authors:  Yang Li; Chunxia Xu; Jinjin Xu; Zifei Qin; Shishi Li; Liufang Hu; Zhihong Yao; Frank J Gonzalez; Xinsheng Yao
Journal:  J Pharm Pharmacol       Date:  2020-07-09       Impact factor: 4.810

7.  Bavachin from Psoralea corylifolia Improves Insulin-Dependent Glucose Uptake through Insulin Signaling and AMPK Activation in 3T3-L1 Adipocytes.

Authors:  Hyejin Lee; Hua Li; Minsoo Noh; Jae-Ha Ryu
Journal:  Int J Mol Sci       Date:  2016-04-08       Impact factor: 5.923

8.  Anti-Inflammatory Activity of Triterpenes Isolated from Protium paniculatum Oil-Resins.

Authors:  Patrícia D O de Almeida; Ana Paula de A Boleti; André Luis Rüdiger; Geane A Lourenço; Valdir Florêncio da Veiga Junior; Emerson S Lima
Journal:  Evid Based Complement Alternat Med       Date:  2015-12-27       Impact factor: 2.629

9.  Quality Assessment of Psoralea fructus by HPLC Fingerprint Coupled with Multi-components Analysis.

Authors:  F Z Yin; L Li; T L Lu; W D Li; B C Cai; W Yin
Journal:  Indian J Pharm Sci       Date:  2015 Nov-Dec       Impact factor: 0.975

10.  Evaluation of the Inhibitory Effects of Bavachinin and Bavachin on Human Monoamine Oxidases A and B.

Authors:  Najla O Zarmouh; Elizabeth A Mazzio; Faisel M Elshami; Samia S Messeha; Suresh V K Eyunni; Karam F A Soliman
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.